Silver dressings: their role in wound management
Top Cited Papers
- 12 December 2006
- journal article
- review article
- Published by Wiley in International Wound Journal
- Vol. 3 (4), 282-294
- https://doi.org/10.1111/j.1742-481x.2006.00265.x
Abstract
Dressings have a part to play in the management of wounds; whether they are sutured or open, usually chronic wounds of many aetiologies which are healing by secondary intention. They traditionally provide a moist wound environment, but this property has been extended through simple to complex, active dressings which can handle excessive exudate, aid in debridement, and promote disorganised, stalled healing. The control of infection remains a major challenge. Inappropriate antibiotic use risks allergy, toxicity and most importantly resistance, which is much reduced by the use of topical antiseptics (such as povidone iodine and chlorhexidine). The definition of what is an antimicrobial and the recognition of infection has proven difficult. Although silver has been recognised for centuries to inhibit infection its use in wound care is relatively recent. Evidence of the efficacy of the growing number of silver dressings in clinical trials, judged by the criteria of the Cochrane Collaboration, is lacking, but there are good indications for the use of silver dressings, to remove or reduce an increasing bioburden in burns and open wounds healing by secondary intention, or to act as a barrier against cross contamination of resistant organisms such as MRSA. More laboratory, and clinical data in particular, are needed to prove the value of the many silver dressings which are now available. Some confusion persists over the measurement of toxicity and antibacterial activity but all dressings provide an antibacterial action, involving several methods of delivery. Nanocrystalline technology appears to give the highest, sustained release of silver to a wound without clear risk of toxicity.Keywords
This publication has 70 references indexed in Scilit:
- The effect of a silver‐containing Hydrofiber® dressing on superficial wound bed and bacterial balance of chronic woundsInternational Wound Journal, 2005
- The use of Acticoat™ in neonatal burnsBurns, 2005
- A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: Comparative patient care auditsBurns, 2005
- Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problemJournal of Hospital Infection, 2005
- Cost‐effective faster wound healing with a sustained silver‐releasing foam dressing in delayed healing leg ulcers – a health‐economic analysisInternational Wound Journal, 2005
- The role of Acticoat™ with nanocrystalline silver in the management of burnsBurns, 2004
- In vitro cytotoxity of silver: implication for clinical wound careBurns, 2004
- Wound Microbiology and Associated Approaches to Wound ManagementClinical Microbiology Reviews, 2001
- Clinical Benefits and Cost Effectiveness of Acticoat as a Dressing for Donor SitesJournal of Burn Care & Rehabilitation, 2001
- Systematic review of antimicrobial agents used for chronic woundsBritish Journal of Surgery, 2001